{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:20:35Z","timestamp":1751430035628,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11230-9","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:12:35Z","timestamp":1751353955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug resistance mutations and phylogenetic analysis of HIV-1 subtypes B and F from mothers and children with vertical transmission"],"prefix":"10.1186","volume":"25","author":[{"given":"Aldicl\u00e9ya Lima","family":"Luz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kledoaldo","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9lcio","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabr\u00edcio Silva","family":"Pess\u00f4a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geovani","family":"de Oliveira Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia Regina","family":"de Andrade Arrais Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Davi Gomes","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Cantalice Santos","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heloisa Ramos","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"11230_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/v15040849","volume":"15","author":"MC Cardenas","year":"2023","unstructured":"Cardenas MC, Farnan S, Hamel BL, Mejia Plazas MC, Sintim-Aboagye E, Littlefield DR, et al. Prevention of the vertical transmission of HIV; A recap of the journey so far. Viruses. 2023;15:849.","journal-title":"Viruses"},{"key":"11230_CR2","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Transforming vision into reality: the 2024 Global Alliance progress report on ending AIDS in children by 2030. 2024. https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/transforming-vision-into-reality. Acessed 25 Dec 2024."},{"key":"11230_CR3","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.6061\/clinics\/2019\/e318","volume":"74","author":"MF Guimar\u00e3es","year":"2019","unstructured":"Guimar\u00e3es MF, Lovero KL, de Avelar JG, Pires LL, de Oliveira GRT, Cosme EM, et al. Review of the missed opportunities for the prevention of vertical transmission of HIV in brazil. Clin (Sao Paulo). 2019;74:e318.","journal-title":"Clin (Sao Paulo)"},{"key":"11230_CR4","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil). Aumenta em 70% o n\u00famero de munic\u00edpios reconhecidos pela elimina\u00e7\u00e3o da transmiss\u00e3o vertical de HIV e s\u00edfilis. 2023. https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2023\/dezembro\/aumenta-em-70-o-numero-de-municipios-reconhecidos-pela-eliminacao-da-transmissao-vertical-de-hiv-e-sifilis. Accessed 25 Dec 2024."},{"key":"11230_CR5","unstructured":"World Health Organization (WHO). HIV drug resistance report 2021. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240038608. Accessed 25 Dec 2024."},{"key":"11230_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1089\/aid.2015.0166","volume":"31","author":"SN Vaz","year":"2015","unstructured":"Vaz SN, Giovanetti M, Rego FF, Oliveira Td, Danaviah S, Gon\u00e7alves ML, et al. Molecular characterization of the human immunodeficiency virus type 1 in women and their vertically infected children. AIDS Res Hum Retroviruses. 2015;31:1046\u201351.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"11230_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/QAD.0000000000002046","volume":"33","author":"A Schultze","year":"2019","unstructured":"Schultze A, Torti C, Cozzi-Lepri A, Vandamme AM, Zazzi M, Sambatakou H, et al. The effect of primary drug resistance on CD4\u2009+\u2009cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy. AIDS. 2019;33:315\u201326.","journal-title":"AIDS"},{"key":"11230_CR8","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.3390\/ijms22105304","volume":"22","author":"A Santos-Pereira","year":"2021","unstructured":"Santos-Pereira A, Triunfante V, Ara\u00fajo PMM, Martins J, Soares H, Poveda E, et al. Nationwide study of drug resistance mutations in HIV-1 infected individuals under antiretroviral therapy in brazil. Int J Mol Sci. 2021;22:5304.","journal-title":"Int J Mol Sci"},{"key":"11230_CR9","doi-asserted-by":"publisher","first-page":"e0007224","DOI":"10.1128\/jvi.00072-24","volume":"98","author":"J Nazziwa","year":"2024","unstructured":"Nazziwa J, Andrews SM, Hou MM, Bruhn CAW, Garcia-Knight MA, Slyker J, et al. Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants. J Virol. 2024;98:e0007224.","journal-title":"J Virol"},{"key":"11230_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40471-021-00268-3","volume":"8","author":"WLA Koay","year":"2021","unstructured":"Koay WLA, Kose-Otieno J, Rakhmanina N. HIV drug resistance in children and adolescents: always a challenge?? Curr Epidemiol Rep. 2021;8:97\u2013107.","journal-title":"Curr Epidemiol Rep"},{"key":"11230_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12981-018-0206-y","volume":"15","author":"N Silver","year":"2018","unstructured":"Silver N, Paynter M, McAllister G, Atchley M, Sayir C, Short J, et al. Characterization of minority HIV-1 drug resistant variants in the united kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay. AIDS Res Ther. 2018;15:18.","journal-title":"AIDS Res Ther"},{"key":"11230_CR12","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/nar\/gku739","volume":"42","author":"D Struck","year":"2014","unstructured":"Struck D, Lawyer G, Ternes A-M, Schmit J-C, Bercoff DP. COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification. Nucleic Acids Res. 2014;42:e144.","journal-title":"Nucleic Acids Res"},{"key":"11230_CR13","unstructured":"HIV Drug Resistance Database. Stanford University. 2024. http:\/\/hivdb.stanford.edu. Accessed 25 Dec 2024."},{"key":"11230_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","volume":"73","author":"KS Lole","year":"1999","unstructured":"Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-Length human immunodeficiency virus type 1 genomes from subtype C-Infected seroconverters in india, with evidence of intersubtype recombination. J Virol. 1999;73:152\u201360.","journal-title":"J Virol"},{"key":"11230_CR15","unstructured":"Stanford University HIV Drug Resistance Database. REGA HIV-1 Subtyping Tool\u2013 Version 3.0. 2024. http:\/\/dbpartners.stanford.edu:8080\/RegaSubtyping\/stanford-hiv\/typingtool. Accessed 25 Dec 2024."},{"key":"11230_CR16","unstructured":"Major HIV-1 Drug Resistance Mutations. 2024.https:\/\/cms.hivdb.org\/prod\/downloads\/resistance-mutation-handout\/resistance-mutation-handout.pdf. Accessed 24 Dec 2024."},{"key":"11230_CR17","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/bioinformatics\/bty121","volume":"34","author":"T Nakamura","year":"2018","unstructured":"Nakamura T, Yamada KD, Tomii K, Katoh K. Parallelization of MAFFT for large-scale multiple sequence alignments. Bioinformatics. 2018;34:2490\u20132.","journal-title":"Bioinformatics"},{"key":"11230_CR18","unstructured":"HIV Sequence Database, Basic Local Alignment Search Tool (BLAST). Los Alamos National Laboratory. https:\/\/www.hiv.lanl.gov\/contentsequence\/BASIC_BLAST\/basic_blast.html. Accessed 25 Dec 2024."},{"key":"11230_CR19","doi-asserted-by":"publisher","first-page":"W232","DOI":"10.1093\/nar\/gkw256","volume":"44","author":"J Trifinopoulos","year":"2016","unstructured":"Trifinopoulos J, Nguyen LT, von Haeseler A, Minh BQ. W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis. Nucl Acids Res. 2016;44:W232\u20135.","journal-title":"Nucl Acids Res"},{"key":"11230_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.clp.2010.08.004","volume":"37","author":"AP Kourtis","year":"2010","unstructured":"Kourtis AP, Bulterys M. Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways. Clin Perinatol. 2010;37:721\u201337.","journal-title":"Clin Perinatol"},{"key":"11230_CR21","doi-asserted-by":"publisher","first-page":"12437","DOI":"10.1128\/JVI.01617-10","volume":"84","author":"EG Ryland","year":"2010","unstructured":"Ryland EG, Tang Y, Christie CD, Feeney ME. Sequence evolution of HIV-1 following mother-to-child transmission. J Virol. 2010;84:12437\u201344.","journal-title":"J Virol"},{"key":"11230_CR22","doi-asserted-by":"publisher","unstructured":"Koay WLA, Kose-Otieno J, Rakhmanina N. HIV Drug Resistance in Children and Adolescents: Always a Challenge? Curr Epidemiol Rep. 2021;8(3):97\u2013107. https:\/\/doi.org\/10.1007\/s40471-021-00268-3","DOI":"10.1007\/s40471-021-00268-3"},{"key":"11230_CR23","first-page":"w20059","volume":"149","author":"F Compagno","year":"2019","unstructured":"Compagno F, Naegele K, Kahlert CR, H\u00f6sli I, Aebi-Popp K, de Tejada BM, et al. The rate of mother-to-child transmission of antiretroviral drug-resistant HIV strains is low in the swiss mother and child HIV cohort study. Swiss Med Wkly. 2019;149:w20059.","journal-title":"Swiss Med Wkly"},{"key":"11230_CR24","doi-asserted-by":"publisher","first-page":"105491","DOI":"10.1016\/j.jcv.2023.105491","volume":"164","author":"G Faraci","year":"2023","unstructured":"Faraci G, Park SY, Dub\u00e9 MP, Lee HY. Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing. J Clin Virol. 2023;164:105491.","journal-title":"J Clin Virol"},{"key":"11230_CR25","doi-asserted-by":"publisher","first-page":"e2217","DOI":"10.1093\/cid\/ciaa1068","volume":"73","author":"S Hackett","year":"2021","unstructured":"Hackett S, Teasdale CA, Pals S, Muttiti A, Mogashoa M, Chang J, et al. Drug resistance mutations among south african children living with HIV on WHO-recommended ART regimens. Clin Infect Dis. 2021;73:e2217\u20132225.","journal-title":"Clin Infect Dis"},{"key":"11230_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/aid.2021.0227","volume":"38","author":"R Karunaianantham","year":"2022","unstructured":"Karunaianantham R, Nesa Kumar M, Gopalan B, Haribabu H, Hanna LE, Sanjeeva GN, et al. Molecular characterization of the pol gene of vertically transmitted HIV-1 strains in children with virological failure. AIDS Res Hum Retroviruses. 2022;38:491\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"11230_CR27","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0140-6736(21)00314-7","volume":"397","author":"S Lockman","year":"2021","unstructured":"Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K, Coletti A, et al. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010\/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet. 2021;397:1276\u201392.","journal-title":"Lancet"},{"key":"11230_CR28","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil), Protocolo cl\u00ednico e diretrizes terap\u00eauticas para preven\u00e7\u00e3o da transmiss\u00e3o vertical de HIV, s\u00edfilis e hepatites virais. 2022. https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/protocolo_clinico_hiv_sifilis_hepatites.pdf. Accessed 25 Dec 2024."},{"issue":"84","key":"11230_CR29","doi-asserted-by":"publisher","first-page":"12437","DOI":"10.1128\/JVI.01617-10","volume":"2010","author":"EG Ryland","year":"2010","unstructured":"Ryland EG, Tang Y, Christie CD, Feeney ME. Sequence evolution of HIV-1 following mother-to-child transmission. J Virol. 2010;2010(84):12437\u201344.","journal-title":"J Virol."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11230-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11230-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11230-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:08:52Z","timestamp":1751396932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11230-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11230"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11230-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the Declaration of Helsinki for research involving human subjects, data and\/or materials. Informed consent to participate was obtained from all of the participants or their guardians in the study. This study was submitted to and approved in accordance with Resolution 466\/2012 by the Research Ethics Committee of the Hospital das Cl\u00ednicas, Federal University of Pernambuco (HC\/UFPE), under CAAE 51758621.7.1001.8807, and the Research Ethics Committee of UFMA, under CAAE 57505422.6.0000.5086.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"811"}}